ICU vs AVTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 19, 2026

ICU

54.1
AI Score
VS
AVTX Wins

AVTX

58.2
AI Score

Investment Advisor Scores

ICU

54score
Recommendation
HOLD

AVTX

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICU AVTX Winner
Net Income -3.52M -64.54M ICU
Operating Income -3.60M -53.18M ICU
ROE -48.1% -70.5% ICU
ROA -31.3% -51.6% ICU
Total Assets 11.26M 125.10M AVTX
Cash 9.35M 26.96M AVTX
Current Ratio 2.73 14.28 AVTX

Relative Price Performance (Last 90 Days)

ICU 1M: -35.1% · 3M: -26.9% AVTX 1M: -4.2% · 3M: +31.7%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 35

RSI (14): 34.6 · Price: $3.20

AVTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $18.05

Fundamentals Snapshot

Metric ICU AVTX
Market Cap
Forward P/E -1.4 -6.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.7% -0.7%
Gross Margin 0.9% -669.9%
Operating Margin -7.3% -1341.6%
EPS -2.38 -5.57
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AVTX is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.